Flonase and Flecainide acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flonase (fluticasone propionate) and Flecainide acetate (flecainide acetate). Common drug interactions include back pain among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Flonase and Flecainide acetate. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Flecainide acetate?

Flecainide acetate has active ingredients of flecainide acetate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 7,176 Flecainide acetate users. Check the latest studies of Flecainide acetate.



On Jul, 12, 2026

81 people who take Flonase and Flecainide acetate together, and have interactions are studied.

Flonase and Flecainide acetate drug interactions.

What are the common drug interactions of Flonase and Flecainide Acetate, by gender? *:

female:

  1. Back pain
  2. Burning sensation
  3. Cellulitis (infection under the skin)
  4. Chronic kidney disease
  5. Costochondritis (chest wall pain)
  6. Drug dependence
  7. Drug level decreased
  8. Dysplasia (enlargement of an organ or tissue)
  9. Ear haemorrhage (bleeding from ear)
  10. Enuresis (repeated inability to control urination)

male:

  1. Pyrexia (fever)
  2. Weight decreased
  3. Fall
  4. Nephrolithiasis (calculi in the kidneys)
  5. Peripheral swelling
  6. Chronic kidney disease
  7. Clavicle fracture
  8. Dyspnoea (difficult or laboured respiration)
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Flonase and Flecainide Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Costochondritis (chest wall pain)
  3. Drug dependence
  4. Enuresis (repeated inability to control urination)
  5. Idiopathic intracranial hypertension (elevated cerebrospinal fluid pressure of unknown cause)
  6. Ventricular extrasystoles (premature cardiac contraction)
  7. Weight increased
  8. Dyspnoea (difficult or laboured respiration)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Renal failure (kidney dysfunction)

40-49:

  1. Hypotension (abnormally low blood pressure)
  2. Tinnitus (a ringing in the ears)
  3. Acute respiratory failure
  4. Asthenia (weakness)
  5. C-reactive protein increased
  6. Dizziness
  7. Loss of consciousness
  8. Lung disorder (lung disease)
  9. Myalgia (muscle pain)
  10. Pyrexia (fever)

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Anxiety
  4. Cardiac failure congestive
  5. Drug hypersensitivity
  6. Drug ineffective
  7. Dyspepsia (indigestion)
  8. Oesophageal pain
  9. Rash erythematous (redness of the skin)
  10. Rash papular (redness with papule)

60+:

  1. Fatigue (feeling of tiredness)
  2. Pyrexia (fever)
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Dizziness
  6. Nausea (feeling of having an urge to vomit)
  7. Pneumonia
  8. Upper respiratory tract infection
  9. Abdominal discomfort
  10. Alopecia (absence of hair from areas of the body)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 14.81%
  2. Immunodeficiency Common Variable: 12 people, 14.81%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 8.64%
  4. Asthma: 7 people, 8.64%
  5. Multiple Myeloma (cancer of the plasma cells): 6 people, 7.41%
  6. High Blood Cholesterol: 6 people, 7.41%
  7. Pain: 5 people, 6.17%
  8. Multiple Allergies (allergy to multiple agents): 5 people, 6.17%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and Flecainide acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flonase and Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flecainide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flonase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flecainide acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate and flecainide acetate (the active ingredients of Flonase and Flecainide acetate, respectively), and Flonase and Flecainide acetate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: